Dr. Tedros Ghebreyesus
The World Health Organization (WHO) says it will temporarily suspend clinical trials of hydroxychloriquine as a potential treatment for COVID-19.
The suspension came after a study revealed that using the drug on COVID-19 patients could increase their likelihood of dying.
Director-General Dr. Tedros Ghebreyesus, who made the revelation at a WHO media briefing, said the decision was made on Saturday following a meeting with 10 of the participating countries.
He said the Data Safety Monitoring Board will review the information regarding the safety of the drug during the period of suspension and the WHO will provide further updates as soon as it knows more.
However, Dr. Ghebreyesus stressed that hydroxychloriquine is accepted as generally safe in the treatment of patients with auto-immune diseases and malaria.
The latest data show that 5.5 million persons have tested positive for coronavirus globally with 344,000 deaths.
The US has recorded 1.6 million cases with nearly 100,000 deaths.